Nikhil S Bardeskar1, Swati P Ahir-Bist1, Preeti R Mehta2, Padmaja Samant-Mavani3, Ruchi Nanavati4, Jayanti Mania-Pramanik5. 1. Department of Infectious Diseases Biology, ICMR-National Institute for Research in Reproductive Health, Parel, Mumbai, 400012, India. 2. Department of Microbiology, Seth G.S. Medical College and KEM Hospital, Parel, Mumbai, 400012, India. 3. Department of Obstetrics and Gynaecology, Seth G.S. Medical College and KEM Hospital, Parel, Mumbai, 400012, India. 4. Department of Neonatology, Seth G.S. Medical College and KEM Hospital, Parel, Mumbai, 400012, India. 5. Department of Infectious Diseases Biology, ICMR-National Institute for Research in Reproductive Health, Parel, Mumbai, 400012, India. jayantimania@rediffmail.com.
Abstract
BACKGROUND: The HIV perinatal transmission in India even after interventions is still high. The anti-retroviral therapy failure rate and the risk of HIV vertical transmission to infants from women with failed treatment during pregnancy also largely remains unevaluated. METHODS: This is a prospective, observational and follow-up study of 18 months to determine the association of ART failure in pregnant women and the subsequent risk of HIV transmission to their infants. A total of 81 mothers were evaluated for ART success/failure by analysing their viral loads. RESULTS: Analyses revealed that a high percentage (19.75%) of women on ART had high viral loads, while the overall HIV transmission rate to the infants was 8.64%. The rate of transmission from women with high viral load was significantly high compared to women with low viral load (37.5% vs. 1.54%; p = 0.0015). CD4 level was not associated with HIV transmission. However, CD4 levels in women, who had successful or failed ART, were significantly different (p = 0.0031). Factors such as mother's age, baby's sex and weight as well as delivery mode were not associated with HIV transmission, however, breastfeeding and viral loads were found to be independently associated with HIV transmission to the neonates. CONCLUSIONS: This study highlights that a significant proportion of women on ART had impaired viral load control. The rate of HIV transmission to infants was also significantly high among these women. This warrants viral load monitoring of HIV infected women to reduce the overall transmission to the infants.
BACKGROUND: The HIV perinatal transmission in India even after interventions is still high. The anti-retroviral therapy failure rate and the risk of HIV vertical transmission to infants from women with failed treatment during pregnancy also largely remains unevaluated. METHODS: This is a prospective, observational and follow-up study of 18 months to determine the association of ART failure in pregnant women and the subsequent risk of HIV transmission to their infants. A total of 81 mothers were evaluated for ART success/failure by analysing their viral loads. RESULTS: Analyses revealed that a high percentage (19.75%) of women on ART had high viral loads, while the overall HIV transmission rate to the infants was 8.64%. The rate of transmission from women with high viral load was significantly high compared to women with low viral load (37.5% vs. 1.54%; p = 0.0015). CD4 level was not associated with HIV transmission. However, CD4 levels in women, who had successful or failed ART, were significantly different (p = 0.0031). Factors such as mother's age, baby's sex and weight as well as delivery mode were not associated with HIV transmission, however, breastfeeding and viral loads were found to be independently associated with HIV transmission to the neonates. CONCLUSIONS: This study highlights that a significant proportion of women on ART had impaired viral load control. The rate of HIV transmission to infants was also significantly high among these women. This warrants viral load monitoring of HIV infectedwomen to reduce the overall transmission to the infants.
Entities:
Keywords:
Anti-retroviral therapy failure; CD4; HIV vertical transmission; HIV-1 transmission; Mother to child transmission; Viral load
Authors: R Nduati; G John; D Mbori-Ngacha; B Richardson; J Overbaugh; A Mwatha; J Ndinya-Achola; J Bwayo; F E Onyango; J Hughes; J Kreiss Journal: JAMA Date: 2000-03-01 Impact factor: 56.272
Authors: L M Mofenson; J S Lambert; E R Stiehm; J Bethel; W A Meyer; J Whitehouse; J Moye; P Reichelderfer; D R Harris; M G Fowler; B J Mathieson; G J Nemo Journal: N Engl J Med Date: 1999-08-05 Impact factor: 91.245
Authors: P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew Journal: N Engl J Med Date: 1999-08-05 Impact factor: 91.245
Authors: Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey Journal: AIDS Date: 2008-05-11 Impact factor: 4.177
Authors: M Tornatore; C V Gonçalves; R A Mendoza-Sassi; J M Silveira; N E D'ávila; C G Maas; M S Bianchi; E M Pinheiro; E S Machado; M A Soares; A M B Martinez Journal: Int J STD AIDS Date: 2010-05 Impact factor: 1.359
Authors: Swati P Ahir; V Chavan; S Kerkar; P Samant-Mavani; R Nanavati; P R Mehta; J Mania-Pramanik Journal: Indian J Med Res Date: 2013 Impact factor: 2.375
Authors: Elizabeth J McFarland; Coleen K Cunningham; Petronella Muresan; Edmund V Capparelli; Charlotte Perlowski; Patricia Morgan; Betsy Smith; Rohan Hazra; Lynette Purdue; Paul A Harding; Gerhard Theron; Hilda Mujuru; Allison Agwu; Murli Purswani; Mobeen H Rathore; Britta Flach; Alison Taylor; Bob C Lin; Adrian B McDermott; John R Mascola; Barney S Graham Journal: J Infect Dis Date: 2021-12-01 Impact factor: 7.759
Authors: Waleed H Mahallawi; Ali Dakhilallah Alsamiri; Alaa Faisal Dabbour; Hamdah Alsaeedi; Abdulmohsen H Al-Zalabani Journal: Front Med (Lausanne) Date: 2021-01-27